abstract |
The present invention is in the field of pharmaceutical treatment of medical conditions associated with diabetes. More specifically, the present invention relates to novel acylated derivatives of human insulin analogs. The present invention also provides pharmaceutical compositions comprising such insulin derivatives, and relates to the use of such derivatives in the treatment or prevention of medical conditions associated with diabetes. |